MacroGenics
MGNX
128 hedge funds and large institutions have $182M invested in MacroGenics in 2024 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 41 increasing their positions, 37 reducing their positions, and 19 closing their positions.
21% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 19
11% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 37
3% more funds holding
Funds holding: 124 → 128 (+4)
0.56% more ownership
Funds ownership: 88.89% → 89.45% (+0.56%)
3% less capital invested
Capital invested by funds: $188M → $182M (-$5.41M)
73% less call options, than puts
Call options by funds: $174K | Put options by funds: $644K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$3.43M |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
+$3.09M |
| 3 |
Morgan Stanley
New York
|
+$2.83M |
| 4 |
JP Morgan Chase
New York
|
+$799K |
| 5 |
Renaissance Technologies
New York
|
+$793K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$2.77M |
| 2 |
Millennium Management
New York
|
-$2.42M |
| 3 |
VPC
Vestal Point Capital
New York
|
-$1.98M |
| 4 |
BlackRock
New York
|
-$1.25M |
| 5 |
PA
Pinnacle Associates
New York
|
-$670K |
MGNX Hedge Fund Activity: Q4 2024 in Review
128 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q4 2024, worth a combined $182M — down 2.9% from $188M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new MGNX positions and 19 closed out — a net gain of 4 holders — while 41 added to existing stakes and 37 trimmed.
The largest buyer was Wasatch Advisors, adding an estimated $3.43M. The largest seller was T. Rowe Price Associates, cutting an estimated $2.77M.
- 128 institutional investors held MacroGenics (MGNX) as of Q4 2024, up from 124 in Q3 2024.
- Funds reported $182M of MacroGenics stock for Q4 2024, down 2.9% quarter-over-quarter.
- 23 funds opened new MacroGenics positions in Q4 2024 and 19 closed out, a net change of +4 holders.
- The largest MacroGenics buyer in Q4 2024 was Wasatch Advisors, an estimated $3.43M added.
- The largest MacroGenics seller in Q4 2024 was T. Rowe Price Associates, an estimated $2.77M sold.
Based on aggregated 13F filings for Q4 2024.